Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 84,930Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1MSN Laboratories

02 1Signa S.A. de C.V.

03 1Viatris

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

02

PharmScience R&D
Not Confirmed

03

PharmScience R&D
Not Confirmed

Looking for 943319-70-8 / Ponatinib API manufacturers, exporters & distributors?

Ponatinib manufacturers, exporters & distributors 1

84

PharmaCompass offers a list of Ponatinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ponatinib manufacturer or Ponatinib supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ponatinib manufacturer or Ponatinib supplier.

PharmaCompass also assists you with knowing the Ponatinib API Price utilized in the formulation of products. Ponatinib API Price is not always fixed or binding as the Ponatinib Price is obtained through a variety of data sources. The Ponatinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Ponatinib

Synonyms

943319-70-8, Ap24534, Ponatinib (ap24534), Ap 24534, Ap-24534, 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide

Cas Number

943319-70-8

Unique Ingredient Identifier (UNII)

4340891KFS

About Ponatinib

Ponatinib is an orally bioavailable multitargeted receptor tyrosine kinase (RTK) inhibitor with potential antiangiogenic and antineoplastic activities. Ponatinib inhibits unmutated and all mutated forms of Bcr-Abl, including T315I, the highly drug therapy-resistant missense mutation of Bcr-Abl. This agent also inhibits other tyrosine kinases including those associated with vascular endothelial growth factor receptors (VEGFRs) and fibroblast growth factor receptors (FGFRs); in addition, it inhibits the tyrosine kinase receptor TIE2 and FMS-related tyrosine kinase receptor-3 (Flt3). RTK inhibition by ponatinib may result in the inhibition of cellular proliferation and angiogenesis and may induce cell death. Bcr-Abl is a fusion tyrosine kinase encoded by the Philadelphia chromosome.

Ponatinib Hydrochloride Manufacturers

A Ponatinib Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ponatinib Hydrochloride, including repackagers and relabelers. The FDA regulates Ponatinib Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ponatinib Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Ponatinib Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Ponatinib Hydrochloride Suppliers

A Ponatinib Hydrochloride supplier is an individual or a company that provides Ponatinib Hydrochloride active pharmaceutical ingredient (API) or Ponatinib Hydrochloride finished formulations upon request. The Ponatinib Hydrochloride suppliers may include Ponatinib Hydrochloride API manufacturers, exporters, distributors and traders.

click here to find a list of Ponatinib Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Ponatinib Hydrochloride USDMF

A Ponatinib Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Ponatinib Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Ponatinib Hydrochloride DMFs exist exist since differing nations have different regulations, such as Ponatinib Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Ponatinib Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Ponatinib Hydrochloride USDMF includes data on Ponatinib Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ponatinib Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Ponatinib Hydrochloride suppliers with USDMF on PharmaCompass.

Ponatinib Hydrochloride Manufacturers | Traders | Suppliers

Ponatinib Hydrochloride Manufacturers, Traders, Suppliers 1
99

We have 3 companies offering Ponatinib Hydrochloride

Get in contact with the supplier of your choice:

  1. MSN Laboratories
  2. Signa S.A. de C.V.
  3. Viatris
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.